Helicobacter pylori infection medical therapy: Difference between revisions
Jump to navigation
Jump to search
Replaced content with "__NOTOC__ {{Helicobacter pylori infection}} {{CMG}} ==Overview== ==Medical Therapy== ===Primary Treatment for H.pylori Infection=== ==References== {{reflist|2}}" |
|||
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
===Primary Treatment for H.pylori Infection=== | ===Primary Treatment for H.pylori Infection=== | ||
{| class="wikitable" | |||
!Primary Therapy | |||
!Sequential Therapy | |||
|- | |||
| | |||
* PPI+Clarithromycin+Amoxicillin or metronidazole | |||
(Clarithromycin-based triple therapy) | |||
* 14 days | |||
or | |||
* PPI or H2RA+ Bismuth+Metronidazole+Tetracycline | |||
(Bismuth quadruple therapy) | |||
* 10-14days | |||
| | |||
* PPI+ Amoxicillin | |||
* 5 days | |||
Followed by | |||
* PPI+Clarithromycin+Tinidazole | |||
* Additional 5 days | |||
(Alternative to clarithromycin-based triple or bismuth quadruple therapy) | |||
|- | |||
|Recommended treatment in the United States | |||
|Requires validation in the United States before it can be recommended as a first line therapy | |||
|} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:09, 17 January 2017
|
Helicobacter pylori infection Microchapters |
|
Differentiating Helicobacter pylori infection from other Diseases |
|---|
|
Diagnosis |
|
Guideline Recommendation |
|
Treatment |
|
Case Studies |
|
Helicobacter pylori infection medical therapy On the Web |
|
American Roentgen Ray Society Images of Helicobacter pylori infection medical therapy |
|
Directions to Hospitals Treating Helicobacter pylori infection |
|
Risk calculators and risk factors for Helicobacter pylori infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Primary Treatment for H.pylori Infection
| Primary Therapy | Sequential Therapy |
|---|---|
(Clarithromycin-based triple therapy)
or
(Bismuth quadruple therapy)
|
Followed by
(Alternative to clarithromycin-based triple or bismuth quadruple therapy) |
| Recommended treatment in the United States | Requires validation in the United States before it can be recommended as a first line therapy |